Type 2 diabetes Archives -

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

https://pharmaphorum.com/news/lillys-new-drug-mounjaro-tirzepatide-wins-us-fda-approval/

News/ News/ R&D

Trial win sets up filings for Lilly’s diabetes blockbuster hope tirzepatide

Phil Taylor Diabetes, Eli Lilly, Novo Nordisk, Ozempic, tirzepatide, Trulicity, Type 2 diabetes 0 Comment

Eli Lilly has scored five out of five with its phase 3 trials of type 2 diabetes candidate

Trial win sets up filings for Lilly’s diabetes blockbuster hope tirzepatide

https://pharmaphorum.com/news/final-trial-win-sets-up-filings-for-lillys-diabetes-blockbuster-hope-tirzepatide/

doctor is sending result of medical test to patient

Digital/ News/ News

Better Therapeutics begins ‘real world’ study of digital diabetes therapy

Richard Staines Better Therapeutics, digital health, digital therapeutics, Type 2 diabetes 0 Comment

After announcing plans to go public, prescription digital therapeutics (DTx) firm Better Therapeutics has begun a “real world”

Better Therapeutics begins ‘real world’ study of digital diabetes therapy

https://pharmaphorum.com/news/better-therapeutics-begins-real-world-study-of-digital-diabetes-therapy/

News/ News/ R&D

Bayer data for kidney disease hope finerenone sets up filings

Phil Taylor AstraZeneca, Bayer, chronic kidney disease, Farxiga, finerenone, Invokana, Johnson & Johnson, SGLT2 inhibitors, Type 2 diabetes 0 Comment

Bayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication

Bayer data for kidney disease hope finerenone sets up filings

https://pharmaphorum.com/news/bayer-data-for-kidney-disease-hope-finerenone-sets-up-filings/

Market Access/ News/ News

Novo launches type 2 diabetes pill in UK after NICE waives review

Richard Staines market access, NICE, Novo Nordisk, Type 2 diabetes 0 Comment

Novo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost-effectiveness watchdog NICE

Novo launches type 2 diabetes pill in UK after NICE waives review

https://pharmaphorum.com/news/novo-launches-type-2-diabetes-pill-in-uk/

Digital/ News/ News/ News/ Patients

NHS backs free behavioural change app for type 2 diabetics

Phil Taylor Changing Health, Diabetes, digital, NHS, Type 2 diabetes 0 Comment

NHS England has awarded a contract to tech company Changing Health to develop a free app to help

NHS backs free behavioural change app for type 2 diabetics

https://pharmaphorum.com/news/nhs-backs-free-behavioural-change-app-for-type-2-diabetics/

Market Access/ News/ News

FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidney disease

Phil Taylor Boehringer Ingelheim, chronic kidney disease, Eli Lilly, Jardiance, Type 2 diabetes 0 Comment

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new

FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidney disease

https://pharmaphorum.com/news/fda-fast-tracks-lilly-boehringers-jardiance-in-chronic-kidney-disease/

Market Access/ News/ News/ News/ Sales and Marketing

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

Phil Taylor Boehringer Ingelheim, combination therapy, Eli Lilly, metabolic disease, Type 2 diabetes 0 Comment

Eli Lilly and Boehringer Ingelheim’s longstanding alliance in diabetes has delivered another new product, this time a three-drug

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

https://pharmaphorum.com/news/lilly-boehringer-bag-fda-okay-for-diabetes-triple-trijardy-xr/

Market Access/ News/ News

AZ’s Forxiga gets heart claim data on its EU label

Phil Taylor AstraZeneca, cardiovascular outcomes, Forxiga, SGLT2 inhibitors, Type 2 diabetes 0 Comment

AstraZeneca has been cleared to include cardiovascular and kidney outcomes data on the label of its type 2

AZ’s Forxiga gets heart claim data on its EU label

https://pharmaphorum.com/news/azs-forxiga-gets-heart-claim-data-on-its-eu-label/

Trending

Type 2 diabetes

Login